Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   Near-infrared uncaging or photosensitizing dictated by oxygen tension
  2. Anderson, E. D.; Gorka, A. P.; Schnermann, M. J.
  3. Nature Communications. 2016, 17-Nov; 7: 13378.
  1. 2.   Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI
  2. Matsumoto, S.; Yasui, H.; Batra, S.; Kinoshita, Y.; Bernardo, M.; Munasinghe, J. P.; Utsumi, H.; Choudhuri, R.; Devasahayam, N.; Subramanian, S.; Mitchell, J. B.; Krishna, M. C.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(42): 17898-17903.
  1. 3.   Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
  2. Rapisarda, A.; Hollingshead, M.; Uranchimeg, B.; Bonomi, C. A.; Borgel, S. D.; Carter, J. P.; Gehrs, B.; Raffeld, M.; Kinders, R. J.; Parchment, R.; Anver, M. R.; Shoemaker, R. H.; Melillo, G.
  3. Molecular Cancer Therapeutics. 2009 8(7): 1867-1877.
  1. 4.   Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts
  2. Papadopoulou, M. V.; Bloomer, W. D.; Taylor, A. P.; Hernandez, M.; Blumenthal, R. D.; Hollingshead, M. G.
  3. Radiation Research. 2007, Jul; 168(1): 65-71.
  1. 5.   MR assessment of changes of tumor in response to hyperbaric oxygen treatment
  2. Matsumoto, K.; Bernardo, M.; Subramanian, S.; Choyke, P.; Mitchell, J. B.; Krishna, M. C.; Lizak, M. J.
  3. Magnetic Resonance in Medicine. 2006, Aug; 56(2): 240-246.
  1. 6.   Meeting report: Exploiting the Tumor Microenvironment for Therapeutics
  2. Melillo, G.; Semenza, G. L.
  3. Cancer Research. 2006, MAY 1; 66(9): 4558-4560.
  1. 7.   Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel
  2. Karaczyn, A.; Ivanov, S.; Reynolds, M.; Zhitkovich, A.; Kasprzak, K. S.; Salnikow, K.
  3. Journal of Cellular Biochemistry. 2006, Apr; 97(5): 1025-1035.
  1. 8.   Absolute oxygen tension (pO(2)) muscle tissue as determined by in murine fatty and EPR
  2. Matsumoto, A.; Matsumoto, S.; Sowers, A. L.; Koscielniak, J. W.; Trigg, N. J.; Kuppusamy, P.; Mitchell, J. B.; Subramanian, S.; Krishna, M. C.; Matsumoto, K.
  3. Magnetic Resonance in Medicine. 2005, DEC; 54(6): 1530-1535.
  1. 9.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 10.   CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2
  2. Iribarren, P.; Chen, K. Q.; Hu, J. Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Uranchimeg, B.; Wang, J. M.
  3. Faseb Journal. 2005, OCT; 19(12): Published as FJ Express article on October 11, 2005.
  1. 11.   NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts
  2. Papadopoulou, M. V.; Bloomer, W. D.; Hollingshead, M. G.
  3. Anticancer Research. 2005, MAY-JUN; 25(3B): 1865-1869.
  1. 12.   Schedule-dependent inhibition of hypoxia-inducible factor-1 alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts
  2. Rapisarda, A.; Zalek, J.; Hollingshead, M.; Braunschweig, T.; Uranchimeg, B.; Bonomi, C. A.; Borgel, S. D.; Carter, J. P.; Hewitt, S. M.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2004, OCT 1; 64(19): 6845-6848.
  1. 13.   Natural inhibitors of carcinogenesis
  2. Kinghorn, A. D.; Su, B. N.; Jang, D. S.; Chang, L. C.; Lee, D.; Gu, J. Q.; Carcache-Blanco, E. J.; Powlus, A. D.; Lee, S. K.; Park, E. J.; Cuendet, M.; Gills, J. J.; Bhat, K.; Park, H. S.; Mata-Greenwood, E.; Song, L. L.; Jong, M. H.; Pezzuto, J. M.
  3. Planta Medica. 2004, AUG; 70(8): 691-705.
  1. 14.   Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages
  2. Bosco, M. C.; Puppo, M.; Pastorino, S.; Mi, Z. H.; Melillo, G.; Massazza, S.; Rapisarda, A.; Varesio, L.
  3. Journal of Immunology. 2004 172(3): 1681-1690.
  1. 15.   Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFN gamma: an approach for gene therapy
  2. Pastorino, S.; Carta, L.; Puppo, M.; Melillo, G.; Bosco, M. C.; Varesio, L.
  3. Gene Therapy. 2004 11(6): 560-568.
  1. 16.   Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: Mechanism and therapeutic implications
  2. Rapisarda, A.; Uranchimeg, B.; Sordet, O.; Pommier, Y.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2004 64(4): 1475-1482.
  1. 17.   Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer
  2. Olive, P. L.; Aquino-Parsons, C.; MacPhail, S. H.; Liao, S. Y.; Raleigh, J. A.; Lerman, M. I.; Stanbridge, E. J.
  3. Cancer Research. 2001 61(24): 8924-8929.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel